Covered recipient · General Payments record
LILA K ORR
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$6,863.60
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $653.20 | 29 |
| Education | $15.27 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $204.30 | 15 |
| PFIZER INC. | $153.42 | 6 |
| Incyte Corporation | $93.05 | 1 |
| E.R. Squibb & Sons, L.L.C. | $73.62 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $45.84 | 1 |
| GENZYME CORPORATION | $28.15 | 1 |
| Janssen Biotech, Inc. | $27.67 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $25.80 | 1 |
| Galderma Laboratories, L.P. | $16.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.10 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158445 | CMS |
| ABBVIE INC. | $20.14 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158447 | CMS |
| ABBVIE INC. | $20.14 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158449 | CMS |
| ABBVIE INC. | $1.32 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158451 | CMS |
| ABBVIE INC. | $7.39 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158453 | CMS |
| ABBVIE INC. | $6.35 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158455 | CMS |
| ABBVIE INC. | $8.27 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158457 | CMS |
| ABBVIE INC. | $26.61 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158459 | CMS |
| ABBVIE INC. | $5.59 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158461 | CMS |
| ABBVIE INC. | $21.26 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158463 | CMS |
| ABBVIE INC. | $21.65 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158465 | CMS |
| ABBVIE INC. | $8.11 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158467 | CMS |
| ABBVIE INC. | $13.37 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158469 | CMS |
| ABBVIE INC. | $9.33 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158471 | CMS |
| ABBVIE INC. | $9.67 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105158473 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.15 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101581872 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.95 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101581895 | CMS |
| E.R. Squibb & Sons, L.L.C. | $29.52 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101581933 | CMS |
| Galderma Laboratories, L.P. | $16.62 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145380900 | CMS |
| GENZYME CORPORATION | $28.15 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139781515 | CMS |
| Incyte Corporation | $93.05 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141218062 | CMS |
| Janssen Biotech, Inc. | $27.67 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078363879 | CMS |
| Novartis Pharmaceuticals Corporation | $45.84 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087330805 | CMS |
| PFIZER INC. | $101.26 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131456676 | CMS |
| PFIZER INC. | $11.51 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131923293 | CMS |
| PFIZER INC. | $15.27 | 08/12/2024 | Education | Undisputed | 01/23/2026 | 1131776435 | CMS |
| PFIZER INC. | $4.47 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131929102 | CMS |
| PFIZER INC. | $13.45 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132102669 | CMS |
| PFIZER INC. | $7.46 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131148473 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $25.80 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152250311 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.